Although chloroquine remains an important therapeutic agent for treatment of malaria in many parts of the world, its safety margin is very narrow. Chloroquine inhibits the cardiac inward rectifier K ؉ current IK1 and can induce lethal ventricular arrhythmias. In this study, we characterized the biophysical and molecular basis of chloroquine block of Kir2.1 channels that underlie cardiac I K1. The voltage-and K ؉ -dependence of chloroquine block implied that the binding site was located within the ion-conduction pathway. Site-directed mutagenesis revealed the location of the chloroquine-binding site within the cytoplasmic pore domain rather than within the transmembrane pore. Molecular modeling suggested that chloroquine blocks Kir2.1 channels by plugging the cytoplasmic conduction pathway, stabilized by negatively charged and aromatic amino acids within a central pocket. Unlike most ionchannel blockers, chloroquine does not bind within the transmembrane pore and thus can reach its binding site, even while polyamines remain deeper within the channel vestibule. These findings explain how a relatively low-affinity blocker like chloroquine can effectively block I K1 even in the presence of high-affinity endogenous blockers. Moreover, our findings provide the structural framework for the design of safer, alternative compounds that are devoid of Kir2.1-blocking properties.
IK1 ͉ ion channel ͉ KCNJ2 ͉ malaria ͉ polyamines C holoroquine remains an important therapeutic agent for the prevention and treatment of malaria in many parts of the world in addition to adjunct therapy for systemic inflammatory disorders. Renewed interest in chloroquine has emerged after recent reports of its effectiveness in reducing viral loads of HIV-1 (1, 2) . Despite its widespread use, chloroquine has a very narrow margin of safety. At therapeutic concentrations, chloroquine causes prolongation of the QT and QRS intervals on the surface electrocardiogram (3, 4) and at higher concentrations causes ventricular ectopy and lethal ventricular arrhythmias (5, 6) . At the cellular level, chloroquine prolongs cardiac action potential duration, enhances automaticity, and reduces the maximum diastolic potential (7) (8) (9) . These cellular and electrocardiographic side effects occur primarily as the result of chloroquine block of the inward rectifier K ϩ current, I K1 (8, 9) and to a lesser degree, block of the rapidly activating delayed rectifier, I Kr (9, 10) .
In the heart, I K1 is the primary determinant of resting membrane potential and contributes to the most terminal phase of action-potential repolarization (11) . The Kir2.x subfamily of potassium channels (Kir2.1, 2.2, and 2.3) underlies cardiac I K1 , assembling either as homo-and/or heterotetrameric channels (12) (13) (14) . However, several lines of evidence suggest that Kir2.1 is the primary determinant of I K1 (15) (16) (17) . For example, mutations in the gene encoding Kir2.1 cause Andersen-Tawil syndrome, a dominantly inherited disorder manifested as ventricular arrhythmias, periodic skeletal muscle paralysis, and dsymorphic features (16) .
A hallmark of Kir2.1 channels is strong inward rectification; that is, the preferential conduction of inward compared with outward current (18) (19) (20) . Inward rectification is not an inherent property of the channel protein itself but reflects strong voltage dependence of channel block by intracellular cations such as Mg 2ϩ and polyamines (putrescine, spermidine, and spermine). The apparent voltage dependence of block is derived from displacement of K ϩ ions across the electrical field by the blocking agent (21) . Negatively charged amino acid residues in the pore-lining M2 helix (D172) and the cytoplasmic pore (E224, D255, D259, and E299) are critical for voltage-dependent block of Kir2.1 channels (21) (22) (23) (24) (25) . Polyamine block likely involves sequential binding to a shallow site in the cytoplasmic pore, followed by progression to a deeper site in the pore-lining M2 helix, displacing K ϩ ions to produce the observed voltage-dependent block (26, 27) .
In this study, we characterized the biophysical and molecular basis of chloroquine block of Kir2.1 channels. Chloroquine blocked Kir2.1 channels from the cytoplasmic surface in a voltage-and K ϩ -dependent manner. Chloroquine reached its binding site, even when Kir2.1 channels were preblocked by polyamines. Based on site-directed mutagenesis and molecular modeling, we propose that chloroquine blocks Kir2.1 channels by plugging the cytoplasmic conduction pathway, stabilized by negatively charged and aromatic amino acids. Our findings explain how a relatively low-affinity blocker like chloroquine can effectively block I K1 even in the presence of high-affinity endogenous blockers and provide a structural framework for the design of safer, alternative compounds that lack Kir2.1-blocking properties.
Results
Chloroquine Preferentially Blocks Outward Current Through Kir2.1 Channels. The effects of chloroquine on Kir2.1 currents were first studied in the whole-cell configuration in transfected HEK293 cells. In control conditions, hyper-and depolarizing pulses of 4-s duration between Ϫ140 and 0 mV elicited large inward currents, but small outward currents, typical of the strong inward rectifier Kir2.1 channel (Fig. 1A) . Chloroquine significantly decreased current amplitude in a voltage-dependent manner with preferential inhibition of outward, compared with inward current (Fig.  1 A and B) . A slow recovery from block was observed during hyperpolarizing pulses to negative membrane potentials ( Fig. 1 A) . The effect of chloroquine on Kir2.1 channels at concentrations Ͻ10 M was completely reversible after 20 min of washout, whereas at higher concentrations it was only partially reversible (data not shown).
To determine the effect of chloroquine on Kir2.1 current in a physiologically relevant setting, we used an action potential voltage clamp protocol. In control conditions, Kir2.1 current was noted to be small or absent during the plateau phase of the action potential, rapidly increased during the terminal phase of repolarization, and declined in early diastole. Chloroquine inhibited the peak outward current in a concentration-dependent manner (Fig. 1C) . The IC 50 of Kir2.1 current elicited by the action potential voltage clamp was 8.7 Ϯ 0.9 M with a Hill coefficient of 1.0 (n ϭ 5 cells, Fig. 1D ).
Chloroquine Blocks from the Cytoplasmic Surface. To determine whether chloroquine preferentially blocks from the cytoplasmic or extracellular surface, we compared the rate of chloroquine block in excised inside-out patches with that observed in the whole-cell configuration. When applied to the cytoplasmic face of excised inside-out patches, chloroquine produced steady-state block in Ϸ15 s, compared with Ϸ8 min. when applied to the external solution in the whole-cell configuration [supporting information (SI) Fig. 6 ). Thus, chloroquine accesses its binding site by entering the channel pore from the cytoplasmic surface.
Voltage Dependence of Chloroquine Block. To determine the voltage dependence of chloroquine block, we measured the onset of block in excised patches where the competing effects of endogenous blockers are absent. Like whole-cell experiments, application of chloroquine in excised inside-out patches caused pronounced dose-dependent block of outward currents (SI Fig.  7 ). The onset of chloroquine block ( block ) was determined by fitting current traces to a monoexponential function and plotting the values vs. membrane potential (SI Fig. 7B ). The voltage dependence of chloroquine block suggested that chloroquine may block Kir2.1 channels within the channel pore similar to other cationic blockers, such as Mg 2ϩ and polyamines. To estimate the distance that chloroquine penetrates the channel pore, we plotted the fraction of unblocked current in the presence of various chloroquine concentrations against membrane voltage (SI Fig. 7D ). The data were fit to a Woodhull equation (28) to yield an apparent K d (at 0 mV) of 27 Ϯ 12 M with an apparent valence (Z) of 2.1 Ϯ 0.6 (n ϭ 6). The apparent valence is a measure of the ability of a blocker to displace K ϩ ions across the membrane electrical field and an indirect measure of the distance penetrated by the blocker. The low valence suggests that chloroquine does not extensively traverse into the channel pore and therefore displaces less K ϩ ions than polyamines, such as spermine [valence Ϸ5 (21, 26) ].
Unblock of Chloroquine at Voltages Negative to EK is [K ؉ ]o Dependent.
A common feature of many charged particles that block ion channels by a pore-plugging mechanism is that unblock is accelerated at elevated [K ϩ ] o , the so-called ''knock-off'' phenomenon (26 (Fig. 2B ). This phenomenon explains, in part, the more complete chloroquine unblock observed in excised patches where [K ϩ ] o ϭ 150 mM (SI Fig. 6C ).
In summary, chloroquine block shares many features of classic intracellular ionic pore blockers, including voltage-dependent block and unblock as well as a knock-off phenomenon in the presence of elevated [K ϩ ] o. The apparent valence of chloroquine block suggests that it penetrates the ion-conduction pathway to displace K ϩ ions but perhaps not as deeply as polyamines. Taken together, these observations suggest that the chloroquinebinding site is located within the ion-conduction pathway. Spermine Does Not Protect Kir2.1 Channels from Chloroquine Block. If the chloroquine-binding site is located within the ion-conduction pathway, we wondered whether the initial binding of polyamines might protect Kir2.1 channels from chloroquine block. To address this question, spermine and chloroquine were sequentially applied to the cytoplasmic face of excised inside-out patches (Fig. 3) . The application of 10 M spermine during depolarization resulted in rapid block, with rapid unblock during membrane hyperpolarization (Fig. 3, trace A) . Application of chloroquine also rapidly blocked outward current but resulted in slow unblock during hyperpolarization (Fig. 3, trace B) . When spermine application was followed by chloroquine, unblock during hyperpolarization was slow (Fig. 3 , trace C), indicating that chloroquine block predominated. Likewise, endogenous Kir2.1 channel blockers (e.g., polyamines and Mg 2ϩ ) did not protect channels from chloroquine block (SI Fig. 8 ). Taken together, these experiments imply that chloroquine binds to a site distinct from that of spermine and other endogenous Kir2.1 channel blockers and that chloroquine can bind to its site even with spermine present within the channel vestibule.
Chloroquine-Binding Site Is Within the Kir2.1 Cytoplasmic Pore. To determine the binding site for chloroquine within the Kir2.1 pore, we sequentially mutated residues in the pore-lining M2 helix (G164-M180) to Ala and assessed the degree of chloroquine block. All Ala-substitutions (G164A-M180A) expressed functional Kir2.1 channels that were effectively blocked by 30 M chloroquine (Fig. 4A) . This observation was consistent with the relatively low apparent valence (Ϸ2) of chloroquine block, suggesting that chloroquine does not penetrate deeply into the In excised, inside-out patches, the membrane was depolarized to ϩ50 mV, followed by cytoplasmic surface application of spermine (10 M), chloroquine (10 M), and combination of spermine, followed by chloroquine. Membrane hyperpolarization to Ϫ80 mV elicited nearly instantaneous inward currents in the presence of spermine alone (rapid spermine unblock) but slowly increasing inward currents in the presence of chloroquine (slow chloroquine unblock) despite preapplication of spermine. channel vestibule. Next, we selectively mutated amino acids that are predicted to face the cytoplasmic pore based on the crystal structure of the Kir2.1 cytoplasmic domain (29) . E224A, D259A, and E299A Kir2.1 channels were markedly resistant to chloroquine block (Fig. 4B and SI Fig. 9 ). The potency of chloroquine block was reduced 635-fold for E224A Kir2.1 channels, 100-fold for E299A, 307-fold for D259A, 14-fold for F254A, and 3-fold for D255A channels. The rank order of importance of Kir2.1 channel residues critical for chloroquine block, E224 Ͼ D259 Ͼ E299 Ͼ F254 Ͼ D255, generally follows the contribution of each residue to polyamine block (25, 30) . The exception is D172A, which is critical for high-affinity polyamine binding but not for binding of chloroquine.
Molecular Modeling of Chloroquine Within the Kir2.1 Cytoplasmic
Domain. Molecular modeling was used to define the lowest energy-minimized docking for chloroquine within the conduction pathway of the Kir2.1 cytoplasmic domain (Fig. 5 B and C) .
In the lowest energy pose, the positively charged alkylamino nitrogen of chloroquine (Fig. 5A) is coordinated by an electronegative ring formed by the eight glutamic acid side chains of residues 224 and 299 (Fig. 5C ). An additional charge-pair interaction is predicted between the positively charged quinoline ring nitrogen and the aspartic acid side chain at position 259. Given the asymmetric structure of chloroquine, this interaction is limited to D259 from a single monomer. The aromatic side chain of Phe at position 254 is directed perpendicular to the quinoline ring (Fig. 5B) , suggesting that T-stacking may stabilize chloroquine within the binding pocket.
Discussion
The inward rectifier potassium current I K1 plays a critical role in the stabilization of the resting membrane potential and in the late repolarization phase of the cardiac action potential (11) . Gain-and loss-of-function mutations in the gene encoding Kir2.1 cause short QT and Andersen-Tawil syndrome, respectively, predisposing affected individuals to ventricular arrhythmias (16, 31, 32) . Recently, it has been suggested that I K1 plays an important role in high-frequency rotor stabilization and ventricular fibrillation dynamics (33) . Thus, modulation of I K1 has important implications for electrical stability in cardiac tissue. In this context, chloroquine block of Kir2.1 channels has significant therapeutic ramifications.
Therapeutic doses of chloroquine typically result in plasma concentrations of 2-3 M, but can achieve peak levels up to 5 M (34). In a large prospective study of acute chloroquine overdose, blood levels ranged from 40 to 80 M (5). Thus, the chloroquine concentrations used in the present study (0.3-30 M) and the IC 50 for block of Kir2.1 current (Ϸ9 M) are within a clinically relevant range.
Chloroquine is a 4-aminoquinoline derivative with two sites of ionization (Fig. 5A) . The pK a values of the alkylamino and amino quinoline ring groups (10.4 and 8.4, respectively) predict that the drug would be 99.9% charged at normal intracellular pH. Similar to other cationic pore blockers, such as quaternary ammonium compounds and piperazine (35, 36) , the voltage and K ϩ dependence suggested that chloroquine blocks Kir2.1 channels from within the conduction pathway. Although the vast majority of ion-channel blockers exert their effects by binding within the transmembrane pore, this is not the case for chloroquine. The low apparent valence of chloroquine block suggested that chloroquine does not penetrate deep into the transmembrane pore. Moreover, spermine was unable to protect Kir2.1 channels from chloroquine blockade. Finally, mutation of residues within the cytoplasmic, but not the transmembrane, pore markedly reduced chloroquine block.
Molecular modeling defined a low-energy docking conformation that suggested charge-pair interactions between the positively charged nitrogens of chloroquine and specific acidic amino acids lining the cytoplasmic conduction pathway. In this pose, the alkylamino nitrogen occupies the center of the conduction pathway, thereby plugging the conduction pore. Of the interactions predicted by the docking model, E224 and D259, likely form the primary chloroquine-binding sites through electrostatic interactions with the alkylamino and quinoline ring nitrogens, respectively.
Although molecular modeling identified electrostatic interactions that are consistent with the site-directed mutagenesis analysis, several important limitations exist. First, we selected the lowest energy-minimized docking for presentation, although other solutions are possible. Second, the Kir2.1 cytoplasmic domain was crystallized without the native transmembrane channel structure and in the absence of the membrane-delimited second messenger phosphatidylinositol 4,5-bisphosphate (PIP 2 ). Thus, the precise location of the critical amino acids in the full-length channel may differ from their position in the isolated cytoplasmic domain crystal structure. Finally, it is not known whether the conformational changes induced by PIP 2 binding (25, 37) alter the orientation of residues lining the cytoplasmic pore. The atomic forces that stabilize chloroquine within the cytoplasmic binding site will be defined ultimately by cocrystallization of chloroquine with the full-length Kir2.1 channel and PIP 2 .
An intriguing question is how a relatively low-affinity cationic drug such as chloroquine may effectively block Kir2.1 channels even in the presence of high-affinity endogenous blockers. We propose that chloroquine and polyamines compete for access to the key cytoplasmic pore domain acidic residues. At depolarized potentials, polyamines preferentially occupy their high-affinity binding site within the channel vestibule, thus chloroquine can access the cytoplasmic pore even while polyamine is bound deep within the channel. Because chloroquine unblock is slow relative to polyamine unblock, chloroquine block predominates at physiological membrane potentials.
Although chloroquine use is declining in many parts of the world because of chloroquine-resistant malaria, new therapeutic indications are arising, most notably for the treatment of HIV. The narrow safety margin of chloroquine could limit its therapeutic potential. Identification of the chloroquine-binding site within the cytoplasmic pore domain will allow for the design of safer chloroquine analogs devoid of Kir2.1 channel blockade.
Materials and Methods
Molecular Biology and Cell Transfection. Kir2.1 cDNA (kind gift of C. Vandenberg, University of California, Santa Barbara) was subcloned into pcDNA3.1(ϩ) plasmid (Invitrogen). Mutations were made by using the QuikChange SiteDirected Mutagenesis kit (Stratagene). All mutations were confirmed by direct DNA sequencing. Kir2.1 constructs were expressed in HEK293 cells as described (38) . Cells were transfected with Lipofectamine 2000 reagent (Invitrogen) according to manufacturer instructions.
Current Recordings in HEK293 Cells. Macroscopic currents were recorded in the whole-cell and inside-out configurations of the patch-clamp technique (39) by using an Axopatch-200B amplifier (Molecular Devices). Data acquisition and command potentials were controlled by pClamp 8.0 software (Molecular Devices). Patch pipettes with a resistance of 1-2 M⍀ were made from borosilicate capillary glass (WPI). For whole-cell recordings, the internal solution contained 100 mM KCl, 10 mM Hepes, 5 mM K 4BAPTA, 5 mM K2ATP, and 1 mM MgCl 2 (pH 7.2). The standard bath solution contained 130 mM NaCl, 4 mM KCl, 1.8 mM CaCl 2, 1 mM MgCl2, 10 mM Hepes and 10 mM glucose (pH 7.4). Inside-out patches were recorded by using Mg 2ϩ -and spermine-free solution on both sides of the patch containing 123 mM KCl, 5 mM K 2EDTA, 7.2 mM K2HPO4, and 8 mM KH2PO4 (pH 7.2). Action potential voltage clamp recordings were performed in HEK293 cells by using the action potential recorded from an isolated feline subendocardial ventricular myocyte as the command signal. Currents elicited in response to the action potential voltage clamp were recorded under control conditions in the presence of chloroquine and after application of 2 mM BaCl2. Kir2.1 currents are represented as Ba 2ϩ -subtracted currents elicited by the action potential voltage clamp.
Drugs. Chloroquine (Sigma) was dissolved directly in the external solution at the desired concentration. HEK293 cells were exposed to chloroquine solutions until steady-state effects were achieved. The effects of chloroquine were measured 8 -10 min after bath application in whole-cell experiments and 15 sec after application in excised inside-out patches. To determine the concentration-effect relationships, a single cell was exposed to cumulative concentrations of chloroquine. Molecular Modeling and Ligand Docking. Molecular modeling was based on the crystal structure of cytoplasmic Kir2.1 domains (PDB ID Code 1U4F) and a structural model of choloroquine (DrugBank, http://redpoll.pharmacy.ualberta.ca/drugbank/) after adjusting its ionization for pK a ϭ 8.04. The docking was initiated from random configurations (n ϭ 50) of the ligand in the cytoplasmic cavity of the Kir2.1 tetramer and performed by using simulated annealing techniques with 1,000 stages, an initial temperature of 500 K, and a final temperature of 300 K. The consistent valence force field (CVFF) was used to calculate conformational energies. Both ligand-and cavity-facing residues of the receptor were kept flexible during the minimization procedure. The lowest energy-minimized conformation was selected for presentation. Modeling, docking, and visualization were performed with Insight II Molecular Modeling System (version 2005; Accelrys) on a four-processor workstation with Linux operating system.
Data

